Response: Long-Term Effects of Micronized AlloDerm Injection for Unilateral Vocal Fold Paralysis

2006 ◽  
Vol 116 (5) ◽  
pp. 846-847 ◽  
Author(s):  
Claudio F. Milstein
Keyword(s):  
Vocal Fold ◽  
Vocal Fold Paralysis ◽  
Unilateral Vocal Fold Paralysis ◽  
Long Term Effects

scholarly journals Long-term Effects of Micronized Alloderm Injection for Unilateral Vocal Fold Paralysis

2005 ◽  
Vol 115 (9) ◽  
pp. 1691-1696 ◽  
Author(s):  
Claudio F. Milstein ◽  
Lee M. Akst ◽  
M Douglas Hicks ◽  
Tom I. Abelson ◽  
Marshall Strome
Keyword(s):  
Vocal Fold ◽  
Vocal Fold Paralysis ◽  
Unilateral Vocal Fold Paralysis ◽  
Long Term Effects

Reduction in Short- and Long-term Pneumonia Rate With Laryngoplasty for Unilateral Vocal Fold Paralysis

2021 ◽  
pp. 019459982110151
Author(s):  
Cheng-Ming Hsu ◽  
Yao-Te Tsai ◽  
Geng-He Chang ◽  
Yao-Hsu Yang ◽  
Tuan-Jen Fang ◽  
...  
Keyword(s):  
Lower Incidence ◽  
Vocal Fold ◽  
Proportional Hazards ◽  
Vocal Fold Paralysis ◽  
Cox Proportional Hazards ◽  
Cox Proportional Hazards Model ◽  
Voice Therapy ◽  
Unilateral Vocal Fold Paralysis ◽  
Short And Long Term

Objective To examine the association of laryngoplasty, voice therapy, and pneumonia rate in patients with unilateral vocal fold paralysis (UVFP). Study Design Population-based retrospective cohort study. Setting Data were collected from the LHID2000 (Longitudinal Health Insurance Database 2000), containing the information of 1 million randomly selected patients in Taiwan. Methods In the LHID2000, we identified 439 patients having new diagnoses of UVFP from 1997 to 2013. We grouped the aforementioned patients according to UVFP treatment and probed the occurrence of pneumonia: 305 patients underwent laryngoplasty or voice therapy, and 134 patients did not undergo treatment. Follow-up procedures were executed for the enrollees until death or December 31, 2013, representing the end of the study period. We assessed the association of UVFP treatment and pneumonia by executing Cox proportional hazards regression. Results The pneumonia cumulative incidence was significantly higher among enrolled patients without treatment than in those receiving treatment ( P < .001). The pneumonia incidence was significantly lower in patients receiving UVFP treatment (hazard ratio, 0.49; 95% CI, 0.27-0.88; P = .018), as validated by the Cox proportional hazards model after adjustment. Patients undergoing laryngoplasty with or without voice therapy had a significantly lower incidence of pneumonia at 6 months and 1, 3, and 5 years, whereas those undergoing voice therapy alone did not. Conclusion Laryngoplasty was associated with a lower incidence of short- and long-term pneumonia in patients with UVFP. Physicians should encourage patients with UVFP at risk of aspiration to receive prompt evaluation as well as treatment.

Long-term voice outcomes of laryngeal framework surgery for unilateral vocal fold paralysis

2021 ◽  
Author(s):  
Stephanie D. Mes ◽  
Martine Hendriksma ◽  
Bas J. Heijnen ◽  
Ben F. J. Goudsmit ◽  
Jeroen C. Jansen ◽  
...  
Keyword(s):  
Vocal Fold ◽  
Vocal Fold Paralysis ◽  
Unilateral Vocal Fold Paralysis ◽  
Laryngeal Framework Surgery

Long-term Results of 18 Fat Injections in Unilateral Vocal Fold Paralysis

2017 ◽  
Vol 31 (4) ◽  
pp. 505.e1-505.e9 ◽  
Author(s):  
R. Pagano ◽  
D. Morsomme ◽  
S. Camby ◽  
L. Lejeune ◽  
C. Finck
Keyword(s):  
Vocal Fold ◽  
Vocal Fold Paralysis ◽  
Long Term Results ◽  
Unilateral Vocal Fold Paralysis

S191 – Unilateral Vocal Fold Paralysis: Medialization Results

2008 ◽  
Vol 139 (2_suppl) ◽  
pp. P191-P192
Author(s):  
Donna Lundy ◽  
Roy R Casiano ◽  
Mario Alberto Landera ◽  
Michael Bublik
Keyword(s):  
Vocal Fold ◽  
Demographic Data ◽  
Vocal Fold Paralysis ◽  
Long Term Results ◽  
Unilateral Vocal Fold Paralysis ◽  
Glottal Closure ◽  
Voice Outcome ◽  
Glottal Insufficiency

Objectives Management of glottal insufficiency due to unilateral vocal fold paralysis (UVFP) has evolved from trans-oral injection to external thyroplasty to revisited injections (transoral or transcutaneous). Currently, preference is given to the less invasive injection medialization. Multiple injectable materials have been utilized with newer ones being introduced to manage concerns over permanency and vocal fold vibratory patterns. The purpose of this study is to evaluate the long-term results of injection medialization for UVFP in terms of stability of glottal closure and voice outcome vs. need for reinjection. Methods All patients with UVFP that underwent injection medialization and had follow-up studies more than 6 months were eligible for inclusion. Parameters studied included demographic data (age, gender), side of paralysis, etiology, degree of pre-injection glottal insufficiency, length of follow-up, degree of post-injection glottal closure, mucosal wave resolution, and Voice Handicap Index. Results 146 patients were identified with a mean age of 61.7 years (17–94); males (55%) and females (45%). Etiology was idiopathic (56%); iatrogenic (48%); tumor-related (9%); trauma (3%); and neurologic (2%). Degree of glottal insufficiency was mild (21%); moderate (29%); and severe (50%). Material injected was Cymetra in 80 patients and Radiesse in 66 patients. 45 (33%) patients underwent more than 1 injection. Details of patients requiring repeat injections with regards to the material injected and the other parameters will be presented. Conclusions Injection medialization via a transcutaneous approach has long-lasting results making it an appropriate minimally-invasive option for long-term medialization for UVFP.

Sign in / Sign up

Export Citation Format

Share Document